Table 2 RISH and marker screening results in all samples
From: Paving the way for more precise diagnosis of EcPV2-associated equine penile lesions
ID | Diagnosis | EcPV2 RISH | p53 | MCM7 | Ki67 | ||||
|---|---|---|---|---|---|---|---|---|---|
GS | DNS | b | nb | b | nb | b | nb | ||
1 | SCC (G3) | pos | 2 | 3 | 2 | 4 | 3 | 1 | 1 |
2 | SCC (G2) | pos | 4 | 4 | 3 | 4 | 2 | 0 | 0 |
3 | SCC (G3) | pos | 7 | 4 | 2 | 4 | 2 | 2 | 1 |
4 | early SCC (G3) | pos | 0 | 4 | 2 | 4 | 2 | 0 | 0 |
5 | early SCC (G3) | pos | 3 | 4 | 3 | 4 | 3 | 3 | 1 |
6 | CIS | pos | 1 | 4 | 3 | 4 | 3 | 3 | 2 |
7 | CIS | (pos) | 0 | 4 | 3 | 4 | 2 | 2 | 1 |
8 | CIS | (pos) | 0 | 2 | 2 | 4 | 3 | 2 | 2 |
9 | Papilloma | pos | 27 | 4 | 1 | 4 | 3 | 1 | 1 |
10 | Papilloma | pos | 0 | 4 | 1 | 4 | 2 | 3 | 1 |
11 | Papilloma | pos | 69 | 4 | 2 | 4 | 4 | 3 | 2 |
12 | Papilloma | pos | 8 | 4 | 1 | 4 | 2 | 2 | 1 |
13 | Papilloma | pos | 14 | 4 | 1 | 4 | 3 | 2 | 1 |
14 | Hyperplasia | pos | 98 | 2 | 1 | 4 | 1 | 1 | 1 |
15 | Hyperplasia | pos | 72 | 3 | 1 | 4 | 2 | 2 | 1 |
16 | Hyperplasia | pos | 27 | 2 | 1 | 4 | 2 | 2 | 1 |
17 | Hyperplasia | pos | 84 | 2 | 1 | 4 | 2 | 3 | 1 |
18 | Hyperplasia | pos | 7 | 4 | 1 | 4 | 2 | 2 | 1 |
19 | Hyperplasia | pos | 49 | 4 | 2 | 4 | 1 | 2 | 1 |
9a | normal adjacent skin | neg | 0 | 2 | 1 | 4 | 1 | 1 | 0 |
12a | normal adjacent skin | neg | 0 | 3 | 2 | 4 | 1 | 1 | 1 |
14a | normal adjacent skin | neg | 0 | 2 | 1 | 4 | 2 | 2 | 1 |
15a | normal adjacent skin | neg | 0 | 3 | 2 | 4 | 1 | 2 | 1 |
16a | normal adjacent skin | neg | 0 | 2 | 1 | 4 | 1 | 2 | 1 |